A Tc1- and Th1-T-lymphocyte-rich tumor microenvironment is a hallmark of MSI colorectal cancer.

Journal: The Journal of pathology
Published Date: Apr 3, 2025

Abstract

Microsatellite instability is a strong predictor of response to immune checkpoint therapy and patient outcome in colorectal cancer. Although enrichment of distinct T-cell subpopulations has been determined to impact the response to immune checkpoint therapy and patient outcome, little is known about the underlying changes in the composition of the immune tumor microenvironment. To assess the density, composition, degree of functional marker expression, and spatial interplay of T-cell subpopulations, 79 microsatellite instable (MSI) and 1,045 microsatellite stable (MSS) colorectal cancers were analyzed. A tissue microarray and large sections were stained with 19 antibodies directed against T cells, antigen-presenting cells, functional markers, and structural proteins using our BLEACH&STAIN multiplex-fluorescence immunohistochemistry approach. A deep learning-based framework comprising >20 different convolutional neuronal networks was developed for image analysis. The composition of Type 1 (T-bet), Type 2 (GATA3), Type 17 (RORγT), NKT-like (CD56), regulatory (FOXP3), follicular (BCL6), and cytotoxic (CD3CD8) or helper (CD3CD4) T cells showed marked differences between MSI and MSS patients. For instance, the fraction of Tc1 and Th1 was significantly higher (p < 0.001 each), while the fraction of Tregs, Th2, and Th17 T cells was significantly lower (p < 0.05) in MSI compared to MSS patients. The degree of TIM3, CTLA-4, and PD-1 expression on most T-cell subpopulations was significantly higher in MSI compared to MSS patients (p < 0.05 each). Spatial analysis revealed increased interactions between Th1, Tc1, and dendritic cells in MSI patients, while in MSS patients the strongest interactions were found between Tregs, Th17, Th2, and dendritic cells. The additional analysis of 12 large sections revealed a divergent immune composition at the invasive margin. In summary, this study identified a higher fraction of Tc1 and Th1 T cells accompanied by a paucity of regulatory T-cell, Th17, and Th2 T-cell subpopulations, along with a distinct interaction profile, as a hallmark of MSI compared to MSS colorectal cancers. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Authors

  • Zhihao Huang
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tim Mandelkow
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Nicolaus F Debatin
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Magalie C J Lurati
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Julia Ebner
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Jonas B Raedler
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Elena Bady
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Jan H Müller
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ronald Simon
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Eik Vettorazzi
    Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Anne Menz
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Katharina Möller
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Natalia Gorbokon
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Guido Sauter
    Sami-Ramzi Leyh-Bannurah, Dirk Pehrke, Hartwig Huland, Markus Graefen, and Lars Budäus, Prostate Cancer Center Hamburg-Eppendorf; Sami-Ramzi Leyh-Bannurah, Margit Fisch, and Guido Sauter, University Medical Center Hamburg-Eppendorf, Hamburg; Ulrich Wolffgang, University of Muenster, Muenster, Germany; and Zhe Tian and Pierre I. Karakiewicz, University of Montreal Health Center, Montreal, Canada.
  • Maximilian Lennartz
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Andreas M Luebke
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Doris Höflmayer
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Till Krech
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Pathology, Clinical Center Osnabrueck, Osnabrueck, Germany.
  • Patrick Lebok
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Christoph Fraune
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Andrea Hinsch
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Frank Jacobsen
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Andreas H Marx
    Institute of Pathology, Klinikum Fürth, Fürth, Germany.
  • Stefan Steurer
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sarah Minner
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • David Dum
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sören Weidemann
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Christian Bernreuther
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Till S Clauditz
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Eike Burandt
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Niclas C Blessin
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Keywords

External Resources

Popular Topics
Recent Journals